Literature DB >> 29513842

Evaluation of in vitro anti-Trypanosoma cruzi activity of medications benznidazole, amiodarone hydrochloride, and their combination.

Angela Maria Lourenço1, Cristiane Castro Faccini1, Cristiane Aparecida de Jesus Costa1, Gabrielle Balestrin Mendes1, Abilio Augusto Fragata Filho1.   

Abstract

INTRODUCTION: Approximately seven to eight million people worldwide have Chagas disease. In Brazil, benznidazole is the most commonly used active drug against Trypanosoma cruzi; however, its efficacy is limited, and side effects are frequent. Recent studies suggest that amiodarone may be beneficial in the treatment of this disease, by exerting anti-T. cruzi action. This study evaluated changes in T. cruzi cell count in in vitro cultures subjected to different doses of benznidazole, amiodarone, and their combination.
METHODS: T. cruzi (Y strain) cultures containing approximately 100,000 cells were treated with either 100mg, 50mg, 25mg, 12.5mg, or 10mg of benznidazole, amiodarone, or their combination. On the 4th day, cell count was compared to the baseline data.
RESULTS: On the 4th day, no parasites were observed in any of the treated cultures.
CONCLUSIONS: Benznidazole and amiodarone were equally effective in eliminating T. cruzi in culture. The combination of the two drugs was also equally effective, but our data cannot demonstrate synergism, as similar results were obtained when the drugs were tested individually or in combination. It is suggested that this study be repeated with other T. cruzi strains to determine whether similar results can be obtained again.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29513842     DOI: 10.1590/0037-8682-0285-2017

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  8 in total

Review 1.  Diagnosis and Management of Chagas Cardiomyopathy in the United States.

Authors:  Lillian Benck; Evan Kransdorf; Jignesh Patel
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

2.  A Combination of Itraconazole and Amiodarone Is Highly Effective against Trypanosoma cruzi Infection of Human Stem Cell-Derived Cardiomyocytes.

Authors:  Gabriele Sass; Roy T Madigan; Lydia-Marie Joubert; Adriana Bozzi; Nazish Sayed; Joseph C Wu; David A Stevens
Journal:  Am J Trop Med Hyg       Date:  2019-08       Impact factor: 2.345

3.  Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning.

Authors:  Melissa F Adasme; Sarah Naomi Bolz; Lauren Adelmann; Sebastian Salentin; V Joachim Haupt; Adriana Moreno-Rodríguez; Benjamín Nogueda-Torres; Verónica Castillo-Campos; Lilián Yepez-Mulia; José A De Fuentes-Vicente; Gildardo Rivera; Michael Schroeder
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

4.  Joining forces: Leveraging novel combination therapies to combat infections with eukaryotic pathogens.

Authors:  Rachel E Ham; Lesly A Temesvari
Journal:  PLoS Pathog       Date:  2020-12-31       Impact factor: 6.823

5.  Synergistic effect and ultrastructural changes in Trypanosoma cruzi caused by isoobtusilactone A in short exposure of time.

Authors:  Júlio Menta de Almeida; Felipe Oliveira Nunes; Lígia Fernanda Ceole; Tabata D'Maiella Freitas Klimeck; Letícia Alves da Cruz; Danilo Tófoli; Beatriz Santana Borges; Walmir Silva Garcez; Inês Aparecida Tozetti; Lia Carolina Soares Medeiros; Fernanda Rodrigues Garcez; Alda Maria Teixeira Ferreira
Journal:  PLoS One       Date:  2021-01-28       Impact factor: 3.240

6.  Advanced management of ventricular arrhythmias in chronic Chagas cardiomyopathy.

Authors:  David Santacruz; Fernando Rosas; Carina Abigail Hardy; Diego Ospina; Andrea Nathalie Rosas; Juan Manuel Camargo; Juan José Bermúdez; Juan Felipe Betancourt; Víctor Manuel Velasco; Mario D González
Journal:  Heart Rhythm O2       Date:  2021-12-17

Review 7.  Immunomodulation for the Treatment of Chronic Chagas Disease Cardiomyopathy: A New Approach to an Old Enemy.

Authors:  Emanuelle de Souza Santos; Dahara Keyse Carvalho Silva; Bruna Padilha Zurita Claro Dos Reis; Breno Cardim Barreto; Carine Machado Azevedo Cardoso; Ricardo Ribeiro Dos Santos; Cássio Santana Meira; Milena Botelho Pereira Soares
Journal:  Front Cell Infect Microbiol       Date:  2021-11-12       Impact factor: 5.293

8.  Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in Trypanosoma cruzi-infected cardiac cells.

Authors:  Juliana Magalhães Chaves Barbosa; Yasmin Pedra-Rezende; Luíza Dantas Pereira; Tatiana Galvão de Melo; Helene Santos Barbosa; Joseli Lannes-Vieira; Solange Lisboa de Castro; Anissa Daliry; Kelly Salomão
Journal:  Front Cell Infect Microbiol       Date:  2022-08-25       Impact factor: 6.073

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.